VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 455 filers reported holding VANECK VECTORS ETF TR in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,839,005 | -82.2% | 105,500 | -80.1% | 0.10% | -82.9% |
Q2 2023 | $15,947,099 | +337.3% | 529,628 | +369.8% | 0.57% | +346.9% |
Q1 2023 | $3,646,945 | -54.0% | 112,734 | -59.2% | 0.13% | -64.9% |
Q4 2022 | $7,926,840 | +8.4% | 276,582 | -31.0% | 0.36% | +9.9% |
Q3 2022 | $7,312,000 | -24.1% | 400,802 | +13.9% | 0.33% | -2.1% |
Q2 2022 | $9,637,000 | -26.6% | 352,000 | -14.2% | 0.34% | +73.8% |
Q4 2021 | $13,134,000 | +4.7% | 410,060 | -3.7% | 0.20% | -36.5% |
Q3 2021 | $12,542,000 | -44.4% | 425,601 | -35.9% | 0.31% | -24.8% |
Q2 2021 | $22,572,000 | +21.6% | 664,304 | +16.3% | 0.41% | +4.1% |
Q1 2021 | $18,566,000 | -18.4% | 571,208 | -9.6% | 0.39% | -34.2% |
Q4 2020 | $22,755,000 | +1.0% | 631,736 | +9.8% | 0.60% | +4.6% |
Q3 2020 | $22,523,000 | -7.0% | 575,162 | -12.8% | 0.57% | +35.7% |
Q2 2020 | $24,206,000 | +7733.7% | 659,929 | +4818.6% | 0.42% | +2370.6% |
Q1 2020 | $309,000 | -99.4% | 13,417 | -99.2% | 0.02% | -97.7% |
Q4 2019 | $49,591,000 | +6.5% | 1,693,642 | -2.9% | 0.74% | -22.9% |
Q3 2019 | $46,579,000 | -11.0% | 1,743,921 | -14.8% | 0.97% | +8.8% |
Q2 2019 | $52,345,000 | +771.5% | 2,047,875 | +664.4% | 0.89% | +508.2% |
Q1 2019 | $6,006,000 | -80.5% | 267,900 | -81.6% | 0.15% | -84.5% |
Q4 2018 | $30,766,000 | -46.8% | 1,458,800 | -53.3% | 0.94% | -10.6% |
Q3 2018 | $57,860,000 | +637.4% | 3,124,176 | +788.3% | 1.05% | +635.7% |
Q2 2018 | $7,847,000 | +47.0% | 351,706 | +44.8% | 0.14% | +70.2% |
Q1 2018 | $5,338,000 | +1048.0% | 242,810 | +1114.0% | 0.08% | +1300.0% |
Q4 2017 | $465,000 | -94.0% | 20,000 | -94.0% | 0.01% | -94.3% |
Q3 2017 | $7,717,000 | -28.2% | 336,112 | -31.0% | 0.10% | -17.3% |
Q2 2017 | $10,749,000 | -78.4% | 486,800 | -77.7% | 0.13% | -78.7% |
Q1 2017 | $49,746,000 | +13.6% | 2,180,891 | +4.2% | 0.60% | +38.9% |
Q4 2016 | $43,795,000 | +6.5% | 2,093,494 | +34.6% | 0.43% | -16.7% |
Q3 2016 | $41,122,000 | +106.4% | 1,555,898 | +116.4% | 0.52% | +136.2% |
Q2 2016 | $19,919,000 | – | 719,100 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |